Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
McKinsey
Fish and Richardson
Novartis
Mallinckrodt
Chinese Patent Office
Accenture
Dow
Teva
Julphar

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070259

« Back to Dashboard

NDA 070259 describes TOLAZAMIDE, which is a drug marketed by Barr, Duramed Pharms Barr, G And W Labs Inc, Interpharm, Mylan Pharms Inc, Par Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, Watson Labs, and Yaopharma Co Ltd, and is included in thirty NDAs. It is available from two suppliers. Additional details are available on the TOLAZAMIDE profile page.

The generic ingredient in TOLAZAMIDE is tolazamide. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the tolazamide profile page.
Summary for 070259
Tradename:TOLAZAMIDE
Applicant:Mylan Pharms Inc
Ingredient:tolazamide
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Pharmacology for NDA: 070259
Ingredient-typeSulfonylurea Compounds
Medical Subject Heading (MeSH) Categories for 070259
Suppliers and Packaging for NDA: 070259
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOLAZAMIDE tolazamide TABLET;ORAL 070259 ANDA Mylan Pharmaceuticals Inc. 0378-0217 N 0378-0217-01
TOLAZAMIDE tolazamide TABLET;ORAL 070259 ANDA Mylan Pharmaceuticals Inc. 0378-0551 N 0378-0551-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Jan 2, 1986TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Mar 17, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
US Department of Justice
Fish and Richardson
Boehringer Ingelheim
Covington
Dow
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot